Edit
ClinSpec Dx
https://www.clinspecdx.com/Last activity: 12.04.2021
Active - Reference to Dxcover
ClinSpec is a diagnostics company which is pioneering a new process using machine learning to identify spectroscopic differences in simple blood serum. This allows same-day detection and grading of a broad range of diseases, with first applications to brain cancer. Alba Equity members participated in the seed funding round in February 2019 when the company was spun-out from the University of Strathclyde.
Employees: 11-50
Total raised: $9.58M
Founded date: 2016
Investors 3
Funding Rounds 3
| Date | Series | Amount | Investors |
| 04.03.2021 | - | $4.86M | - |
| 08.09.2020 | - | $3.2M | - |
| 29.05.2019 | - | $1.52M | - |
Mentions in press and media 15
| Date | Title | Description |
| 12.04.2021 | The DIGIT Deal Roundup Column | March 2021 | Funding and Investment Swipii Glasgow-based tech startup Swipii has launched its first-ever crowdfund as it seeks to quadruple its business network to help power the Shop Local recovery last month. Hosted by Crowdcube, the firm is seeking £... |
| 03.04.2021 | Clinspec Diagnostics Limited announced that it has received £3.5 million in funding from a group of investors | On March 4, 2021, Clinspec Diagnostics Limited closed the transaction. The company amended the terms of transaction and received £1.1 million in its second tranche. The company raised £3.5 million in this transaction. The second tranche was... |
| 04.03.2021 | ClinSpec Diagnostics Closes £3.5M Funding | ClinSpec Diagnostics Limited, a Glasgow, Scotland, UK-based developer of liquid biopsies for early detection of cancer, secured an additional funding of £1.1M and closed its target of £3.5M. The £1.1m investment was made by Norcliffe Capita... |
| 04.03.2021 | Glasgow biotech develops easy blood test for early cancer diagnosis, adds £3.5M funding | Earlier cancer diagnosis results in significantly higher survival rates, increasing the availability of treatment options and improving recovery chances and a better quality of life. Additionally, the blood test has the potential to indicat... |
| 04.03.2021 | ClinSpec Diagnostics Secures Second Major Funding Boost | ClinSpec Diagnostics, (ClinSpec Dx), the Glasgow-based developer of liquid biopsies for early detection of cancer, has reached its £3.5m investment target after a second major funding round. The University of Strathclyde spinout has secured... |
| 14.10.2020 | DIGIT Deal Roundup | September 2020 | Funding Bellrock Technology Scottish data analytics innovator Bellrock Technology has successfully listed for the first time on a public sector framework that has generated more than £6 billion in contracts since 2012. The Glasgow-based fir... |
| 08.09.2020 | ClinSpec Secures £2.4m in Funding for Early Cancer Detection Tech | ClinSpec Diagnostics Limited (ClinSpec Dx) has secured £2.4 million in investment from Social Investment Scotland to help develop a new technology that can detect cancer at an early stage using blood tests. The ClinSpec Dx blood test uses a... |
| 07.09.2020 | ClinSpec Diagnostics Raises £2.4M Funding | ClinSpec Diagnostics, a Glasgow, Scotland-based early cancer detection company, raised £2.4m in funding. The round was led by Mercia’s EIS Funds with Scottish Investment Bank, the investment arm of Scottish Enterprise, profit with purpose i... |
| 07.09.2020 | Glasgow-based ClinSpec Diagnostics secures $3.2M to improve the early detection of cancer | ClinSpec Diagnostics (ClinSpec Dx), a Glasgow-based tech startup with a mission to improve the early detection of cancer, today announced it has raised $3.2 million (£2.4 million) to support the further development of innovative testing tec... |
| 13.07.2020 | Applied AI 1.0: What Happened Next? | Almost exactly a year ago today, we announced that we were launching our very first artificial intelligence growth programme. After months of searching, and a tough round of judging, we announced our very first Applied AI cohort in Septembe... |
Show more